Opportunities and Challenges of Kava in Lung Cancer Prevention
International Journal of Molecular Sciences · 31.05.2023 · 24 (11) · 9539
DOI: 10.3390/ijms24119539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.05.2023. Verfasst von Breanne Freeman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development, College of Pharmacy, University of Florida, Gaines…. Hauptthemen laut MEDLINE: Kava, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Florida Department of Health James and Esther King Biomedical Research Program.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths due to its high incidence, late diagnosis, and limited success in clinical treatment. Prevention therefore is critical to help improve lung cancer management. Although tobacco control and tobacco cessation are effective strategies for lung cancer prevention, the numbers of current and former smokers in the USA and globally are not expected to decrease significantly in the near future. Chemoprevention and interception are needed to help high-risk individuals reduce their lung cancer risk or delay lung cancer development. This article will review the epidemiological data, pre-clinical animal data, and limited clinical data that support the potential of kava in reducing human lung cancer risk via its holistic polypharmacological effects. To facilitate its future clinical translation, advanced knowledge is needed with respect to its mechanisms of action and the development of mechanism-based non-invasive biomarkers in addition to safety and efficacy in more clinically relevant animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
- Department of Biostatistics, College of Public Health & Health Professions, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Psychiatry, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
- Department of Pharmacology, PennState Cancer Institute, Penn State University College of Medicine, Hershey, PA 17033, USA.
ORCID-Profile: Tengfei Bian, Carolyn J Baglole, Ramzi G Salloum, Chengguo Xing
Förderung
- Florida Department of Health James and Esther King Biomedical Research Program
Zitieren
APA
Freeman, B., Mamallapalli, J., Bian, T., Ballas, K., Lynch, A., Scala, A., Huo, Z., Fredenburg, K. M., Bruijnzeel, A. W., Baglole, C. J., Lu, J., Salloum, R. G., Malaty, J., & Xing, C. (2023). Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences, 24(11), 9539. https://doi.org/10.3390/ijms24119539
Vancouver
Freeman B, Mamallapalli J, Bian T, Ballas K, Lynch A, Scala A, et al. Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences. 2023;24(11):9539. doi:10.3390/ijms24119539
BibTeX
@article{Freeman2023,
author = {Freeman, Breanne and Mamallapalli, Jessica and Bian, Tengfei and Ballas, Kayleigh and Lynch, Allison and Scala, Alexander and Huo, Zhiguang and Fredenburg, Kristianna M and Bruijnzeel, Adriaan W and Baglole, Carolyn J and Lu, Junxuan and Salloum, Ramzi G and Malaty, John and Xing, Chengguo},
title = {Opportunities and Challenges of Kava in Lung Cancer Prevention},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {11},
pages = {9539},
doi = {10.3390/ijms24119539}
}
EUVIMED